Abiopharma

🔍 Grygiel Nancy A. (Executive)

Company: AMGEN INC (AMGN)

Report Date: 2025-08-20

Detailed Transactions and Holdings:

• Sold 1,267 shares of Common Stock at $296.985 per share (Direct)
  Date: 2025-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,209.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-20 | Code: H | nature_of_ownership: 401(k) Plan | shares_owned_after: 103.81 | Footnotes: F2

Footnotes:

• F1: These shares include 80 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
• F2: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.